LOS ANGELES — For the first time in more than four decades, the drug lysergic acid diethylamide – better known as LSD – has been the experimental adjunct to psychotherapy in a controlled clinical trial approved by the U.S. Food and Drug Administration.[1]
LOS ANGELES — For the first time in more than four decades, the drug lysergic acid diethylamide – better known as LSD – has been the experimental adjunct to psychotherapy in a controlled clinical trial approved by the U.S. Food and Drug Administration.[1]
[1]http://www.pressherald.com/news/First_clinical_trial_of_LSD_...